Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Peptide-based vaccination: where do we stand?
Journal article

Peptide-based vaccination: where do we stand?

Abstract

PURPOSE OF REVIEW: Allergen-specific immunotherapy represents the only causative approach towards allergy treatment. Specific immunotherapy can, however, include allergic reactions and occasionally life-threatening anaphylaxis. Peptides have been evaluated as a potential therapeutic approach in atopic allergic disease because they have the potential to inhibit T-cell function but not induce anaphylaxis. RECENT FINDINGS: Data from early clinical …

Authors

Francis JN; Larché M

Journal

Current Opinion in Allergy and Clinical Immunology, Vol. 5, No. 6, pp. 537–543

Publisher

Wolters Kluwer

Publication Date

December 2005

DOI

10.1097/01.all.0000191234.97760.88

ISSN

1528-4050